New injection shows promise in reversing dangerous liver scarring

NCT ID NCT04929483

Completed Disease control Sponsor: 89bio, Inc. Source: ClinicalTrials.gov ↗

Summary

This study tested whether a new drug called BIO89-100 could help people with a serious fatty liver disease called NASH. 222 adults with confirmed liver scarring received either the drug or a placebo injection weekly for 24 weeks. Researchers checked if the treatment could reduce liver inflammation and improve scarring without making things worse.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

89bio Clinical Study Site

Birmingham, Alabama, 35209, United States
89bio Clinical Study Site

Birmingham, Alabama, 35211, United States
89bio Clinical Study Site

Dothan, Alabama, 36305, United States
89bio Clinical Study Site

Guntersville, Alabama, 35976, United States
89bio Clinical Study Site

Madison, Alabama, 35758, United States
89bio Clinical Study Site

Chandler, Arizona, 85224, United States
89bio Clinical Study Site

Glendale, Arizona, 85036, United States
89bio Clinical Study Site

Peoria, Arizona, 85306, United States
89bio Clinical Study Site

Tucson, Arizona, 85712-4044, United States
89bio Clinical Study Site

Tucson, Arizona, 85712-4046, United States
89bio Clinical Study Site

Tucson, Arizona, 85741, United States
89bio Clinical Study Site

Little Rock, Arkansas, 72205-6414, United States
89bio Clinical Study Site

Little Rock, Arkansas, 72205, United States
89bio Clinical Study Site

Chula Vista, California, 91911, United States
89bio Clinical Study Site

Huntington Park, California, 90255, United States
89bio Clinical Study Site

Long Beach, California, 90808, United States
89bio Clinical Study Site

Orange, California, 92866, United States
89bio Clinical Study Site

Panorama City, California, 91402, United States
89bio Clinical Study Site

Rialto, California, 92377, United States
89bio Clinical Study Site

Santa Ana, California, 92704, United States
89bio Clinical Study Site

Englewood, Colorado, 80113, United States
89bio Clinical Study Site

Boynton Beach, Florida, 33472, United States
89bio Clinical Study Site

Bradenton, Florida, 34208, United States
89bio Clinical Study Site

Fort Myers, Florida, 33912, United States
89bio Clinical Study Site

Lakeland, Florida, 33805, United States
89bio Clinical Study Site

Maitland, Florida, 32127, United States
89bio Clinical Study Site

Miami, Florida, 33014, United States
89bio Clinical Study Site

Miami, Florida, 33147, United States
89bio Clinical Study Site

Miami, Florida, 33157, United States
89bio Clinical Study Site

Miami Lakes, Florida, 33016, United States
89bio Clinical Study Site

Ocala, Florida, 34471, United States
89bio Clinical Study Site

Palmetto Bay, Florida, 33157, United States
89bio Clinical Study Site

Pinellas Park, Florida, 33781, United States
89bio Clinical Study Site

Port Orange, Florida, 32127, United States
89bio Clinical Study Site

Sarasota, Florida, 34240, United States
89bio Clinical Study Site

Viera, Florida, 32940, United States
89bio Clinical Study Site

Athens, Georgia, 30607, United States
89bio Clinical Study Site

Sandy Springs, Georgia, 30328, United States
89bio Clinical Study Site

New Albany, Indiana, 47150, United States
89bio Clinical Study Site

South Bend, Indiana, 46635, United States
89bio Clinical Study Site

Iowa City, Iowa, 52246, United States
89bio Clinical Study Site

Topeka, Kansas, 66606, United States
89bio Clinical Study Site

Marrero, Louisiana, 70072-3151, United States
89bio Clinical Study Site

Marrero, Louisiana, 70072-3155, United States
89bio Clinical Study Site

Monroe, Louisiana, 71201, United States
89bio Clinical Study Site

Shreveport, Louisiana, 71103, United States
89bio Clinical Study Site

Glen Burnie, Maryland, 21061, United States
89bio Clinical Study Site

Greenbelt, Maryland, 20770, United States
89bio Clinical Study Site

St Louis, Missouri, 63033, United States
89bio Clinical Study Site

Las Vegas, Nevada, 89119, United States
89bio Clinical Study Site

Las Vegas, Nevada, 89121, United States
89bio Clinical Study Site

Florham Park, New Jersey, 07932, United States
89bio Clinical Study Site

New York, New York, 10033, United States
89bio Clinical Study Site

Concord, North Carolina, 28027, United States
89bio Clinical Study Site

Columbus, Ohio, 43210, United States
89bio Clinical Study Site

Dayton, Ohio, 45414, United States
89bio Clinical Study Site

Springboro, Ohio, 45066, United States
89bio Clinical Study Site

Westlake, Ohio, 44145, United States
89bio Clinical Study Site

Greenwood, South Carolina, 29646, United States
89bio Clinical Study Site

Summerville, South Carolina, 29485, United States
89bio Clinical Study Site

Chattanooga, Tennessee, 37411, United States
89bio Clinical Study Site

Chattanooga, Tennessee, 37421, United States
89bio Clinical Study Site

Hermitage, Tennessee, 37076, United States
89bio Clinical Study Site

Austin, Texas, 78757-8051, United States
89bio Clinical Study Site

Austin, Texas, 78757-8059, United States
89bio Clinical Study Site

Beaumont, Texas, 77702, United States
89bio Clinical Study Site

Dallas, Texas, 75234, United States
89bio Clinical Study Site

Dallas, Texas, 75246, United States
89bio Clinical Study Site

Edinburg, Texas, 78539, United States
89bio Clinical Study Site

Fort Worth, Texas, 76104, United States
89bio Clinical Study Site

Garland, Texas, 75044, United States
89bio Clinical Study Site

Houston, Texas, 77030, United States
89bio Clinical Study Site

Houston, Texas, 77099, United States
89bio Clinical Study Site

San Antonio, Texas, 78209, United States
89bio Clinical Study Site

San Antonio, Texas, 78215, United States
89bio Clinical Study Site

San Antonio, Texas, 78229-4801, United States
89bio Clinical Study Site

San Antonio, Texas, 78229-5069, United States
89bio Clinical Study Site

Waco, Texas, 76710, United States
89bio Clinical Study Site

Waco, Texas, 76712, United States
89bio Clinical Study Site

Wichita Falls, Texas, 76301, United States
89bio Clinical Study Site

Ogden, Utah, 84405, United States
89bio Clinical Study Site

Sandy City, Utah, 84092, United States
89bio Clinical Study Site

Manassas, Virginia, 20110, United States
89bio Clinical Study Site

Richmond, Virginia, 23235, United States
89bio Clinical Study Site

Richmond, Virginia, 23249, United States
89bio Clinical Study Site

Roanoke, Virginia, 24014, United States
89bio Clinical Study Site

Seattle, Washington, 98105, United States
89bio Clinical Study Site

Spokane, Washington, 99202, United States
89bio Clinical Study Site

San Juan, 00927, Puerto Rico

Conditions

Explore the condition pages connected to this study.

NASH - NONALCOHOLIC STEATOHEPATITIS